Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion (068270) to List 41,475 Additional Common Shares Following Exercise of Stock Options

Posted on February 10, 2025July 16, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion (068270) to List 41,475 Additional Common Shares Following Exercise of Stock Options

Source Facts: Financial Supervisory Service Electronic Disclosure System (DART) / 2025-02-10

Disclosure Type: Additional Listing (Exercise of Stock Options)

💡 3-Second Summary

Celltrion has announced the additional listing of 41,475 common shares on February 13, 2025, which were newly issued following the exercise of stock options.

📊 1. [Key Disclosure Content & Key Metrics Summary]

  • Type and Number of Additional Shares: 41,475 registered common shares (Par value: KRW 1,000 per share)
  • Issue Price and Volume by Round:
    • Round 150: KRW 49,499 per share (16,976 shares)
    • Round 151: KRW 78,213 per share (22,899 shares)
    • Round 152: KRW 169,828 per share (800 shares)
    • Round 153: KRW 134,308 per share (500 shares)
    • Round 154: KRW 170,330 per share (300 shares)
  • Key Timeline & General Details:
    • Issue Date: January 23, 2025
    • Listing Date: February 13, 2025
    • Dividend Accrual Date: January 1, 2025 (Fiscal year-end: December 31)
    • Method of Capital Increase: Exercise of stock options

📈 2. [Expert View: What This Disclosure Means for Investors]

  • Verification of Issuance Conditions: This additional listing consists of stock options exercised across five rounds (Rounds 150 to 154). As the issue prices vary by round, ranging from KRW 49,499 to KRW 170,330, investors should check the distinct price points and quantities for each round.
  • Monitoring Market Supply and Demand: On the official listing date of February 13, 2025, the newly issued 41,475 common shares will become available for trading in the market. Consequently, observing the subsequent transaction volumes and general market supply-demand dynamics after listing is recommended.
  • Tracking Total Outstanding Shares: The exercise of stock options introduces new shares into the company’s capital structure. The exact adjustments should be cross-referenced with future updates on the company’s total outstanding share count.

📝 Editor’s Comment (by K-STOCK Editor)

An additional listing filing following the exercise of stock options represents the standard administrative listing process resulting from previously granted options being executed. Therefore, this informational disclosure does not indicate any direct change to the company’s underlying operational performance or fundamental business value.

The practical focus for market participants is to note the schedule and scale provided in the document. With 41,475 shares set to be listed on February 13, 2025, monitoring the actual trading volume and checking for any changes in market supply around the listing date represents the standard course of observation.

In conclusion, investors should verify that the additional listing is finalized as scheduled on February 13, and observe the subsequent market supply-demand metrics following the share issuance.

📢 Disclaimer & Source Information

Source: This content has been newly structured and written based on official disclosure data submitted to the Financial Supervisory Service’s Electronic Disclosure System (DART).

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest solely with the investor.

Contact: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Isu Petasys (007660) Adjusts New Share Listing Date to May 2; KRW 250B Rights Offering Fully Headed for Facilities Post-M&A Scrapping
Next Post: [Disclosure] Prosecution Appeals After SAMSUNG BIOLOGICS(207940) Cleared in Appellate Court Over Alleged Accounting Rule Violations… Case Moves to Supreme Court

Related Posts

[Disclosure] Celltrion (068270) Submits Phase 3 Clinical Trial Application (IND) for ‘Keytruda Biosimilar (CT-P51)’ to South Korean MFDS Disclosures
[Disclosure] JUSUNG ENGINEERING (036930) Executes Relisting Following Total Retirement of 980,891 Treasury Shares to Enhance Shareholder Value Semiconductors
[Disclosure] Hanwha Ocean (042660) Formally Terminates Acquisition Discussions with Australian Defense and Shipbuilding Firm ‘Austal’ Disclosures
[Disclosure] SK hynix (000660) Joins Gov’t Corporate Value-Up Program: Unveils Strategic Roadmap Capitalized by CapEx Discipline & Enhanced Shareholder Returns Semiconductors
[Disclosure] Daeduck Electronics (353200) Pre-Announces Q1 2024 Earnings Release Date for ‘May 2’! Semiconductors
[Disclosure] SK hynix (000660) Finalizes Blockbuster USD 3.87B Advanced Packaging Fab in Indiana, Securing AI Supply Chain Dominance in North America Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme